DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Heerspink H, Perkins B, Fitchett D. et al.
SGLT2 inhibitors in the treatment of diabetes: Cardiovascular and kidney effects, potential mechanisms and clinical applications.
Circulation 2016;
134: 752-772
We do not assume any responsibility for the contents of the web pages of other providers.